Global Cell and Advanced Therapies Supply Chain Management Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cell and Advanced Therapies Supply Chain Management Market Size 2017-2028

2.1.2 Cell and Advanced Therapies Supply Chain Management Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Cell and Advanced Therapies Supply Chain Management Segment by Type

2.2.1 Cloud

2.2.2 On-premises

2.3 Cell and Advanced Therapies Supply Chain Management Market Size by Type

2.3.1 Cell and Advanced Therapies Supply Chain Management Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2017-2022)

2.4 Cell and Advanced Therapies Supply Chain Management Segment by Application

2.4.1 Biobank

2.4.2 Cell Therapy Lab

2.4.3 Hospital

2.4.4 Research Institute

2.4.5 Commercial Organization

2.5 Cell and Advanced Therapies Supply Chain Management Market Size by Application

2.5.1 Cell and Advanced Therapies Supply Chain Management Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application (2017-2022)

3 Cell and Advanced Therapies Supply Chain Management Market Size by Player

3.1 Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Players

3.1.1 Global Cell and Advanced Therapies Supply Chain Management Revenue by Players (2020-2022)

3.1.2 Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Players (2020-2022)

3.2 Global Cell and Advanced Therapies Supply Chain Management Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Cell and Advanced Therapies Supply Chain Management by Regions

4.1 Cell and Advanced Therapies Supply Chain Management Market Size by Regions (2017-2022)

4.2 Americas Cell and Advanced Therapies Supply Chain Management Market Size Growth (2017-2022)

4.3 APAC Cell and Advanced Therapies Supply Chain Management Market Size Growth (2017-2022)

4.4 Europe Cell and Advanced Therapies Supply Chain Management Market Size Growth (2017-2022)

4.5 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size Growth (2017-2022)

5 Americas

5.1 Americas Cell and Advanced Therapies Supply Chain Management Market Size by Country (2017-2022)

5.2 Americas Cell and Advanced Therapies Supply Chain Management Market Size by Type (2017-2022)

5.3 Americas Cell and Advanced Therapies Supply Chain Management Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cell and Advanced Therapies Supply Chain Management Market Size by Region (2017-2022)

6.2 APAC Cell and Advanced Therapies Supply Chain Management Market Size by Type (2017-2022)

6.3 APAC Cell and Advanced Therapies Supply Chain Management Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Cell and Advanced Therapies Supply Chain Management by Country (2017-2022)

7.2 Europe Cell and Advanced Therapies Supply Chain Management Market Size by Type (2017-2022)

7.3 Europe Cell and Advanced Therapies Supply Chain Management Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cell and Advanced Therapies Supply Chain Management by Region (2017-2022)

8.2 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Type (2017-2022)

8.3 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Cell and Advanced Therapies Supply Chain Management Market Forecast

10.1 Global Cell and Advanced Therapies Supply Chain Management Forecast by Regions (2023-2028)

10.1.1 Global Cell and Advanced Therapies Supply Chain Management Forecast by Regions (2023-2028)

10.1.2 Americas Cell and Advanced Therapies Supply Chain Management Forecast

10.1.3 APAC Cell and Advanced Therapies Supply Chain Management Forecast

10.1.4 Europe Cell and Advanced Therapies Supply Chain Management Forecast

10.1.5 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Forecast

10.2 Americas Cell and Advanced Therapies Supply Chain Management Forecast by Country (2023-2028)

10.2.1 United States Cell and Advanced Therapies Supply Chain Management Market Forecast

10.2.2 Canada Cell and Advanced Therapies Supply Chain Management Market Forecast

10.2.3 Mexico Cell and Advanced Therapies Supply Chain Management Market Forecast

10.2.4 Brazil Cell and Advanced Therapies Supply Chain Management Market Forecast

10.3 APAC Cell and Advanced Therapies Supply Chain Management Forecast by Region (2023-2028)

10.3.1 China Cell and Advanced Therapies Supply Chain Management Market Forecast

10.3.2 Japan Cell and Advanced Therapies Supply Chain Management Market Forecast

10.3.3 Korea Cell and Advanced Therapies Supply Chain Management Market Forecast

10.3.4 Southeast Asia Cell and Advanced Therapies Supply Chain Management Market Forecast

10.3.5 India Cell and Advanced Therapies Supply Chain Management Market Forecast

10.3.6 Australia Cell and Advanced Therapies Supply Chain Management Market Forecast

10.4 Europe Cell and Advanced Therapies Supply Chain Management Forecast by Country (2023-2028)

10.4.1 Germany Cell and Advanced Therapies Supply Chain Management Market Forecast

10.4.2 France Cell and Advanced Therapies Supply Chain Management Market Forecast

10.4.3 UK Cell and Advanced Therapies Supply Chain Management Market Forecast

10.4.4 Italy Cell and Advanced Therapies Supply Chain Management Market Forecast

10.4.5 Russia Cell and Advanced Therapies Supply Chain Management Market Forecast

10.5 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Forecast by Region (2023-2028)

10.5.1 Egypt Cell and Advanced Therapies Supply Chain Management Market Forecast

10.5.2 South Africa Cell and Advanced Therapies Supply Chain Management Market Forecast

10.5.3 Israel Cell and Advanced Therapies Supply Chain Management Market Forecast

10.5.4 Turkey Cell and Advanced Therapies Supply Chain Management Market Forecast

10.5.5 GCC Countries Cell and Advanced Therapies Supply Chain Management Market Forecast

10.6 Global Cell and Advanced Therapies Supply Chain Management Forecast by Type (2023-2028)

10.7 Global Cell and Advanced Therapies Supply Chain Management Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Be The Match BioTherapies

11.1.1 Be The Match BioTherapies Company Information

11.1.2 Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Product Offered

11.1.3 Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Be The Match BioTherapies Main Business Overview

11.1.5 Be The Match BioTherapies Latest Developments

11.2 Brooks Life Sciences

11.2.1 Brooks Life Sciences Company Information

11.2.2 Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Product Offered

11.2.3 Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Brooks Life Sciences Main Business Overview

11.2.5 Brooks Life Sciences Latest Developments

11.3 Clarkston Consulting

11.3.1 Clarkston Consulting Company Information

11.3.2 Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Product Offered

11.3.3 Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Clarkston Consulting Main Business Overview

11.3.5 Clarkston Consulting Latest Developments

11.4 Cryoport

11.4.1 Cryoport Company Information

11.4.2 Cryoport Cell and Advanced Therapies Supply Chain Management Product Offered

11.4.3 Cryoport Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Cryoport Main Business Overview

11.4.5 Cryoport Latest Developments

11.5 Haemonetics

11.5.1 Haemonetics Company Information

11.5.2 Haemonetics Cell and Advanced Therapies Supply Chain Management Product Offered

11.5.3 Haemonetics Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Haemonetics Main Business Overview

11.5.5 Haemonetics Latest Developments

11.6 Hypertrust Patient Data Care

11.6.1 Hypertrust Patient Data Care Company Information

11.6.2 Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Product Offered

11.6.3 Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Hypertrust Patient Data Care Main Business Overview

11.6.5 Hypertrust Patient Data Care Latest Developments

11.7 Lykan Bioscience

11.7.1 Lykan Bioscience Company Information

11.7.2 Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Product Offered

11.7.3 Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Lykan Bioscience Main Business Overview

11.7.5 Lykan Bioscience Latest Developments

11.8 MAK-SYSTEM

11.8.1 MAK-SYSTEM Company Information

11.8.2 MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Product Offered

11.8.3 MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 MAK-SYSTEM Main Business Overview

11.8.5 MAK-SYSTEM Latest Developments

11.9 MasterControl

11.9.1 MasterControl Company Information

11.9.2 MasterControl Cell and Advanced Therapies Supply Chain Management Product Offered

11.9.3 MasterControl Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 MasterControl Main Business Overview

11.9.5 MasterControl Latest Developments

11.10 SAP

11.10.1 SAP Company Information

11.10.2 SAP Cell and Advanced Therapies Supply Chain Management Product Offered

11.10.3 SAP Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 SAP Main Business Overview

11.10.5 SAP Latest Developments

11.11 SAVSU Technologies

11.11.1 SAVSU Technologies Company Information

11.11.2 SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Product Offered

11.11.3 SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 SAVSU Technologies Main Business Overview

11.11.5 SAVSU Technologies Latest Developments

11.12 sedApta Group

11.12.1 sedApta Group Company Information

11.12.2 sedApta Group Cell and Advanced Therapies Supply Chain Management Product Offered

11.12.3 sedApta Group Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 sedApta Group Main Business Overview

11.12.5 sedApta Group Latest Developments

11.13 Stafa Cellular Therapy

11.13.1 Stafa Cellular Therapy Company Information

11.13.2 Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Product Offered

11.13.3 Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Stafa Cellular Therapy Main Business Overview

11.13.5 Stafa Cellular Therapy Latest Developments

11.14 Title21 Health Solutions

11.14.1 Title21 Health Solutions Company Information

11.14.2 Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Product Offered

11.14.3 Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Title21 Health Solutions Main Business Overview

11.14.5 Title21 Health Solutions Latest Developments

11.15 TraceLink

11.15.1 TraceLink Company Information

11.15.2 TraceLink Cell and Advanced Therapies Supply Chain Management Product Offered

11.15.3 TraceLink Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 TraceLink Main Business Overview

11.15.5 TraceLink Latest Developments

11.16 TrakCel

11.16.1 TrakCel Company Information

11.16.2 TrakCel Cell and Advanced Therapies Supply Chain Management Product Offered

11.16.3 TrakCel Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 TrakCel Main Business Overview

11.16.5 TrakCel Latest Developments

11.17 Vineti

11.17.1 Vineti Company Information

11.17.2 Vineti Cell and Advanced Therapies Supply Chain Management Product Offered

11.17.3 Vineti Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Vineti Main Business Overview

11.17.5 Vineti Latest Developments

12 Research Findings and Conclusion

Table 1. Cell and Advanced Therapies Supply Chain Management Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Cloud

Table 3. Major Players of On-premises

Table 4. Cell and Advanced Therapies Supply Chain Management Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Cell and Advanced Therapies Supply Chain Management Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2017-2022)

Table 7. Cell and Advanced Therapies Supply Chain Management Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Cell and Advanced Therapies Supply Chain Management Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application (2017-2022)

Table 10. Global Cell and Advanced Therapies Supply Chain Management Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Player (2020-2022)

Table 12. Cell and Advanced Therapies Supply Chain Management Key Players Head office and Products Offered

Table 13. Cell and Advanced Therapies Supply Chain Management Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Cell and Advanced Therapies Supply Chain Management Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Regions (2017-2022)

Table 18. Americas Cell and Advanced Therapies Supply Chain Management Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Country (2017-2022)

Table 20. Americas Cell and Advanced Therapies Supply Chain Management Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2017-2022)

Table 22. Americas Cell and Advanced Therapies Supply Chain Management Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application (2017-2022)

Table 24. APAC Cell and Advanced Therapies Supply Chain Management Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Region (2017-2022)

Table 26. APAC Cell and Advanced Therapies Supply Chain Management Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2017-2022)

Table 28. APAC Cell and Advanced Therapies Supply Chain Management Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application (2017-2022)

Table 30. Europe Cell and Advanced Therapies Supply Chain Management Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Country (2017-2022)

Table 32. Europe Cell and Advanced Therapies Supply Chain Management Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2017-2022)

Table 34. Europe Cell and Advanced Therapies Supply Chain Management Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Cell and Advanced Therapies Supply Chain Management

Table 43. Key Market Challenges & Risks of Cell and Advanced Therapies Supply Chain Management

Table 44. Key Industry Trends of Cell and Advanced Therapies Supply Chain Management

Table 45. Global Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share Forecast by Application (2023-2028)

Table 51. Be The Match BioTherapies Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors

Table 52. Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Product Offered

Table 53. Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Be The Match BioTherapies Main Business

Table 55. Be The Match BioTherapies Latest Developments

Table 56. Brooks Life Sciences Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors

Table 57. Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Product Offered

Table 58. Brooks Life Sciences Main Business

Table 59. Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Brooks Life Sciences Latest Developments

Table 61. Clarkston Consulting Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors

Table 62. Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Product Offered

Table 63. Clarkston Consulting Main Business

Table 64. Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Clarkston Consulting Latest Developments

Table 66. Cryoport Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors

Table 67. Cryoport Cell and Advanced Therapies Supply Chain Management Product Offered

Table 68. Cryoport Main Business

Table 69. Cryoport Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Cryoport Latest Developments

Table 71. Haemonetics Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors

Table 72. Haemonetics Cell and Advanced Therapies Supply Chain Management Product Offered

Table 73. Haemonetics Main Business

Table 74. Haemonetics Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Haemonetics Latest Developments

Table 76. Hypertrust Patient Data Care Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors

Table 77. Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Product Offered

Table 78. Hypertrust Patient Data Care Main Business

Table 79. Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Hypertrust Patient Data Care Latest Developments

Table 81. Lykan Bioscience Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors

Table 82. Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Product Offered

Table 83. Lykan Bioscience Main Business

Table 84. Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Lykan Bioscience Latest Developments

Table 86. MAK-SYSTEM Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors

Table 87. MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Product Offered

Table 88. MAK-SYSTEM Main Business

Table 89. MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. MAK-SYSTEM Latest Developments

Table 91. MasterControl Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors

Table 92. MasterControl Cell and Advanced Therapies Supply Chain Management Product Offered

Table 93. MasterControl Main Business

Table 94. MasterControl Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. MasterControl Latest Developments

Table 96. SAP Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors

Table 97. SAP Cell and Advanced Therapies Supply Chain Management Product Offered

Table 98. SAP Main Business

Table 99. SAP Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. SAP Latest Developments

Table 101. SAVSU Technologies Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors

Table 102. SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Product Offered

Table 103. SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. SAVSU Technologies Main Business

Table 105. SAVSU Technologies Latest Developments

Table 106. sedApta Group Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors

Table 107. sedApta Group Cell and Advanced Therapies Supply Chain Management Product Offered

Table 108. sedApta Group Main Business

Table 109. sedApta Group Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. sedApta Group Latest Developments

Table 111. Stafa Cellular Therapy Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors

Table 112. Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Product Offered

Table 113. Stafa Cellular Therapy Main Business

Table 114. Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. Stafa Cellular Therapy Latest Developments

Table 116. Title21 Health Solutions Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors

Table 117. Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Product Offered

Table 118. Title21 Health Solutions Main Business

Table 119. Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. Title21 Health Solutions Latest Developments

Table 121. TraceLink Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors

Table 122. TraceLink Cell and Advanced Therapies Supply Chain Management Product Offered

Table 123. TraceLink Main Business

Table 124. TraceLink Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 125. TraceLink Latest Developments

Table 126. TrakCel Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors

Table 127. TrakCel Cell and Advanced Therapies Supply Chain Management Product Offered

Table 128. TrakCel Main Business

Table 129. TrakCel Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 130. TrakCel Latest Developments

Table 131. Vineti Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors

Table 132. Vineti Cell and Advanced Therapies Supply Chain Management Product Offered

Table 133. Vineti Main Business

Table 134. Vineti Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 135. Vineti Latest Developments

List of Figures

Figure 1. Cell and Advanced Therapies Supply Chain Management Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Cell and Advanced Therapies Supply Chain Management Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type in 2021

Figure 7. Cell and Advanced Therapies Supply Chain Management in Biobank

Figure 8. Global Cell and Advanced Therapies Supply Chain Management Market: Biobank (2017-2022) & ($ Millions)

Figure 9. Cell and Advanced Therapies Supply Chain Management in Cell Therapy Lab

Figure 10. Global Cell and Advanced Therapies Supply Chain Management Market: Cell Therapy Lab (2017-2022) & ($ Millions)

Figure 11. Cell and Advanced Therapies Supply Chain Management in Hospital

Figure 12. Global Cell and Advanced Therapies Supply Chain Management Market: Hospital (2017-2022) & ($ Millions)

Figure 13. Cell and Advanced Therapies Supply Chain Management in Research Institute

Figure 14. Global Cell and Advanced Therapies Supply Chain Management Market: Research Institute (2017-2022) & ($ Millions)

Figure 15. Cell and Advanced Therapies Supply Chain Management in Commercial Organization

Figure 16. Global Cell and Advanced Therapies Supply Chain Management Market: Commercial Organization (2017-2022) & ($ Millions)

Figure 17. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application in 2021

Figure 18. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Player in 2021

Figure 19. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Regions (2017-2022)

Figure 20. Americas Cell and Advanced Therapies Supply Chain Management Market Size 2017-2022 ($ Millions)

Figure 21. APAC Cell and Advanced Therapies Supply Chain Management Market Size 2017-2022 ($ Millions)

Figure 22. Europe Cell and Advanced Therapies Supply Chain Management Market Size 2017-2022 ($ Millions)

Figure 23. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size 2017-2022 ($ Millions)

Figure 24. Americas Cell and Advanced Therapies Supply Chain Management Value Market Share by Country in 2021

Figure 25. Americas Cell and Advanced Therapies Supply Chain Management Consumption Market Share by Type in 2021

Figure 26. Americas Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application in 2021

Figure 27. United States Cell and Advanced Therapies Supply Chain Management Market Size Growth 2017-2022 ($ Millions)

Figure 28. Canada Cell and Advanced Therapies Supply Chain Management Market Size Growth 2017-2022 ($ Millions)

Figure 29. Mexico Cell and Advanced Therapies Supply Chain Management Market Size Growth 2017-2022 ($ Millions)

Figure 30. Brazil Cell and Advanced Therapies Supply Chain Management Market Size Growth 2017-2022 ($ Millions)

Figure 31. APAC Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Region in 2021

Figure 32. APAC Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application in 2021

Figure 33. China Cell and Advanced Therapies Supply Chain Management Market Size Growth 2017-2022 ($ Millions)

Figure 34. Japan Cell and Advanced Therapies Supply Chain Management Market Size Growth 2017-2022 ($ Millions)

Figure 35. Korea Cell and Advanced Therapies Supply Chain Management Market Size Growth 2017-2022 ($ Millions)

Figure 36. Southeast Asia Cell and Advanced Therapies Supply Chain Management Market Size Growth 2017-2022 ($ Millions)

Figure 37. India Cell and Advanced Therapies Supply Chain Management Market Size Growth 2017-2022 ($ Millions)

Figure 38. Australia Cell and Advanced Therapies Supply Chain Management Market Size Growth 2017-2022 ($ Millions)

Figure 39. Europe Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Country in 2021

Figure 40. Europe Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type in 2021

Figure 41. Europe Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application in 2021

Figure 42. Germany Cell and Advanced Therapies Supply Chain Management Market Size Growth 2017-2022 ($ Millions)

Figure 43. France Cell and Advanced Therapies Supply Chain Management Market Size Growth 2017-2022 ($ Millions)

Figure 44. UK Cell and Advanced Therapies Supply Chain Management Market Size Growth 2017-2022 ($ Millions)

Figure 45. Italy Cell and Advanced Therapies Supply Chain Management Market Size Growth 2017-2022 ($ Millions)

Figure 46. Russia Cell and Advanced Therapies Supply Chain Management Market Size Growth 2017-2022 ($ Millions)

Figure 47. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Region in 2021

Figure 48. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type in 2021

Figure 49. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application in 2021

Figure 50. Egypt Cell and Advanced Therapies Supply Chain Management Market Size Growth 2017-2022 ($ Millions)

Figure 51. South Africa Cell and Advanced Therapies Supply Chain Management Market Size Growth 2017-2022 ($ Millions)

Figure 52. Israel Cell and Advanced Therapies Supply Chain Management Market Size Growth 2017-2022 ($ Millions)

Figure 53. Turkey Cell and Advanced Therapies Supply Chain Management Market Size Growth 2017-2022 ($ Millions)

Figure 54. GCC Country Cell and Advanced Therapies Supply Chain Management Market Size Growth 2017-2022 ($ Millions)

Figure 55. Americas Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 56. APAC Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 57. Europe Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 58. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 59. United States Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 60. Canada Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 61. Mexico Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 62. Brazil Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 63. China Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 64. Japan Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 65. Korea Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 66. Southeast Asia Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 67. India Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 68. Australia Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 69. Germany Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 70. France Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 71. UK Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 72. Italy Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 73. Russia Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 74. Spain Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 75. Egypt Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 76. South Africa Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 77. Israel Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 78. Turkey Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)

Figure 79. GCC Countries Cell and Advanced Therapies Supply Chain Management Market Size 2023-2028 ($ Millions)